Todd W Vanderah
Works at
Professor27 Aug 2026reporter.nih.gov
Grants and prizes
UG3PNA5 For Treatment of Vascular Cognitive Impairment and Dementia (VCID) and Alzheimer's disease related dementias (ADRD): A Phase 1a Safety and Tolerability StudyUG3AG1046422026–202727 Aug 2026reporter.nih.gov
U01PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology StudyU01AG0826172023–202713 Aug 2026reporter.nih.gov
U01PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology StudyU01AG0826172023–202716 Jul 2026reporter.nih.gov